BAIJIN LIFE SCI(01466): Independent non-executive director Huang Zhaoqiang has been appointed as chairman of the audit committee.

18:00 27/01/2026

Baijin Life Sciences (01466) announced that Mr. Li Jialiang has resigned as an independent non-executive director for personal reasons, and will no longer serve as chairman of the company's audit committee, as well as a member of the remuneration committee and nomination committee, effective from January 27, 2026.

BAIJIN LIFE SCI (01466) announced that Mr. Li Jialiang has resigned as an independent non-executive director due to personal reasons and will no longer serve as the chairman of the company's audit committee, as well as a member of the remuneration committee and nomination committee, effective from January 27, 2026. The Board of Directors announced that following Mr. Li's resignation, Mr. Wong Siu Keung has been appointed as the chairman of the audit committee, effective from January 27, 2026.

CF PHARMTECH (02652) spent HK$421,300 to repurchase 12,000 shares on January 27th.

YIDU TECH (02158) spent approximately 2.27 million Hong Kong dollars to repurchase 37.86 million shares on January 27th.

MARKETINGFORCE (02556) spent 3.2925 million Hong Kong dollars to repurchase 7.08 thousand shares on January 27th.

CF PHARMTECH (02652) spent HK$421,300 to repurchase 12,000 shares on January 27th.

YIDU TECH (02158) spent approximately 2.27 million Hong Kong dollars to repurchase 37.86 million shares on January 27th.

MARKETINGFORCE (02556) spent 3.2925 million Hong Kong dollars to repurchase 7.08 thousand shares on January 27th.